/
RSS Feed
Annual Meeting of the American College of Cardiology March 11-14, 2006, Atlanta: Atheroma Reversal, Statins for Acute Coronary Syndromes, Targeting Dual Antiplatelet Therapy, Clopidogrel and Drug Eluting Stents, Catheter Ablation for Atrial Fibrillation
James Tcheng, Duke University, Durham, NC
REFERENCE: American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The 2006 meeting of the ACC in Atlanta heard from Steven Nissen of the Cleveland Clinic, Ohio how atheroma was observed to significantly regress among patients treated with a statin in the ASTEROID study, and from Anthony Bavry – also of the Clinic – on how early aggressive use of statins helped patients with acute coronary syndromes. Peter Goodwin discussed these findings with James Tcheng who also talks about the CHARISMA trial of dual anti-platelet therapy reported to the ACC by the Cleveland Clinic’s Deepak Bhatt, the BASKET study of late stent thrombosis in drug eluting stents presented in Atlanta by Matthias Pfisterer from the University of Basel, and results of Carlo Pappone from San Raffaele University, Milan, on radio frequency ablation for paroxysmal atrial fibrillation.
[audio:https://www.audiomedica.com/podcasting/ajc/06.05.18-Cardio12.1Part1.mp3] James Tcheng, Duke University, Durham, NC
REFERENCE: American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The 2006 meeting of the ACC in Atlanta heard from Steven Nissen of the Cleveland Clinic, Ohio how atheroma was observed to significantly regress among patients treated with a statin in the ASTEROID study, and from Anthony Bavry – also of the Clinic – on how early aggressive use of statins helped patients with acute coronary syndromes. Peter Goodwin discussed these findings with James Tcheng who also talks about the CHARISMA trial of dual anti-platelet therapy reported to the ACC by the Cleveland Clinic’s Deepak Bhatt, the BASKET study of late stent thrombosis in drug eluting stents presented in Atlanta by Matthias Pfisterer from the University of Basel, and results of Carlo Pappone from San Raffaele University, Milan, on radio frequency ablation for paroxysmal atrial fibrillation.
